trending Market Intelligence /marketintelligence/en/news-insights/trending/vEczJjaWSWD5NGoJr01qMw2 content esgSubNav
In This List

Recro Pharma plans to sell $40M of common stock

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Recro Pharma plans to sell $40M of common stock

Recro Pharma, Inc. plans to sell up to $40 million of its common shares from time to time.

Cowen and Co. LLC will act as the placement agent for the offering.